See every side of every news story
Published loading...Updated

Dual Immunotherapy Approved for Mexicans with Advanced Melanoma

It is estimated that more than 2,000 Mexicans live with melanoma, the most dangerous skin cancer. Unfortunately, 8 out of 10 cases are diagnosed in advanced stages. Mexico City.- Bristol Myers Squibb biopharmaceutical (BMS) Mexico announced that it received authorization for a drug that combines two immunotherapies for the treatment of adults and children over 12 years of age with unresectable or metastatic melanoma; that is, that it cannot be r…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right

Staff/RG It is estimated that more than 2,000 Mexicans live with melanoma , the most dangerous skin cancer . Unfortunately, 8 out of 10 cases are diagnosed in advanced stages In order to offer new treatment options that give hope to patients, the combination of two Bristol Myers Squibb immunotherapies for adults and children over 12 years of age with unresectable or metastatic melanoma was authorized in Mexico .

It is estimated that more than 2,000 Mexicans live with melanoma, the most dangerous skin cancer. Unfortunately, 8 out of 10 cases are diagnosed in advanced stages. Mexico City.- Bristol Myers Squibb biopharmaceutical (BMS) Mexico announced that it received authorization for a drug that combines two immunotherapies for the treatment of adults and children over 12 years of age with unresectable or metastatic melanoma; that is, that it cannot be r…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

El Heraldo de Saltillo broke the news in on Tuesday, July 8, 2025.
Sources are mostly out of (0)